3/26
09:19 am
viri
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID [Yahoo! Finance]
High
Report
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID [Yahoo! Finance]
3/26
09:15 am
viri
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
Medium
Report
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
2/29
09:19 am
viri
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/29
09:15 am
viri
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Low
Report
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
2/28
09:33 am
viri
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones [Yahoo! Finance]
Neutral
Report
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones [Yahoo! Finance]
2/28
09:15 am
viri
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
Low
Report
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
1/22
09:15 am
viri
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID [Yahoo! Finance]
High
Report
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID [Yahoo! Finance]
1/22
09:00 am
viri
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
High
Report
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
11/13/2023
07:05 am
viri
virios therapeutics, inc.
BEAT
Report
-11.1%
virios therapeutics, inc.
8/10/2023
07:05 am
viri
virios therapeutics, inc.
MISS
Report
-32.9%
virios therapeutics, inc.
3/8
05:01 pm
viri
Form 10-K/A Virios Therapeutics, For: Dec 31
Low
Report
Form 10-K/A Virios Therapeutics, For: Dec 31
3/6
04:30 pm
viri
Form 8-K Virios Therapeutics, For: Mar 01
Medium
Report
Form 8-K Virios Therapeutics, For: Mar 01
3/1
09:11 am
viri
Form 10-K Virios Therapeutics, For: Dec 31
High
Report
Form 10-K Virios Therapeutics, For: Dec 31
2/29
09:25 am
viri
Form 8-K Virios Therapeutics, For: Feb 29
Low
Report
Form 8-K Virios Therapeutics, For: Feb 29
2/28
01:19 pm
viri
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Pridgen William
Low
Report
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Pridgen William
2/28
01:10 pm
viri
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Thomas John C
Low
Report
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Thomas John C
2/28
01:04 pm
viri
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Whitley Richard James
Low
Report
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Whitley Richard James
2/28
01:02 pm
viri
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Keefer David R
Low
Report
Form 4 Virios Therapeutics, For: Feb 26 Filed by: Keefer David R
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register